Anaesthesia in the casualty department.

Anaesthesia in the casualty department. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Anaesthesia in the casualty department. Abstract Text:

J R ROOK,

Anaesthesia in the casualty department. Publishing Authors By Initials

JR ROOK,

For similar anesthesia and analgesia: anesthesia research abstracts see: anesthesia and analgesia: anesthesia research

PUBMED ID PMID:

MEDLINE DATE:

Anaesthesia in the casualty department. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Lancet

VOLUME: 1

Page Numbers: 1202-5

Journal Abbreviation: Lancet

ISSN: 0140-6736

DAY: 14

MONTH: Jun

YEAR: 1952

Anaesthesia in the casualty department. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2985213

Anaesthesia in the casualty department. Keywords Mesh Terms:

KEYWORDS: Anesthesia

MESH TERMS:

Chemical & Substance for Abstract: Anaesthesia in the casualty department. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Anaesthesia in the casualty department.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Lancet

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Anaesthesia in the casualty department Related Publications

• Alan Filmer ROOK.
• An investigation into the longevity of Cambridge sportsmen.
• Anaesthesia in the casualty department.
• Apoptotic responses to all-trans retinoic acid of targretin-resistant, malignant, CD4+ peripheral blood T cells from patients with Sezary syndrome.
• Biological effects of bexarotene in cutaneous T-cell lymphoma.
• CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.
• Cutaneous arteriolitis.
• Dealing with negative social exchanges in later life: coping responses, goals, and effectiveness.
• Denileukin diftitox for the treatment of panniculitic lymphoma.
• Gas chromatographic alkylation studies of phenytoin, mephenytoin and primidone: Investigation of butylated derivatives.
• Gene expression of IL17 and IL23 in the lungs of patients with active tuberculosis.
• IL-21 Enhances Antitumor Responses without Stimulating Proliferation of Malignant T Cells of Patients with Sézary Syndrome.
• Identification of clonal T cells in the blood of patients with systemic sclerosis: positive correlation with response to photopheresis.
• Idiopathic thrombocythemia.
• Idiopathic thrombocythemia.
• Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results.
• Lethal vascular leak syndrome after denileukin diftitox administration to a patient with cutaneous gamma/delta T-cell lymphoma and occult cirrhosis.
• Livedo reticularis.
• Management of anaesthesia of the severely burned patient.
• New biologic agents for the treatment of cutaneous T-cell lymphoma.
• Pseudoxanthoma elasticum.
• Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12.
• The addition of interferon gamma to oral bexarotene therapy with photopheresis for Sézary syndrome.
• The hygiene hypothesis and the increasing prevalence of chronic inflammatory disorders.
• The sign of Leser-Trélat in association with Sézary syndrome: simultaneous disappearance of seborrheic keratoses and malignant T-cell clone during combined therapy with photopheresis and interferon alfa.
• The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA encoding the antagonistic splice variant, IL-4delta2, is not.
• Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome.
• Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution.
• Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod.
• Understanding recent regulatory guidelines for hospital-acquired catheter-related urinary tract infections and pressure ulcers.